Compare GSK plc (GSK) vs Plug Power Inc (PLUG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Plug Power Inc — how do they compare? GSK plc trades at $52.41 (market cap $101.34B), while Plug Power Inc trades at $2.2 (market cap $3.08B). The key difference: GSK plc is far larger — about 32.9× Plug Power Inc's market cap, and GSK plc pays a 3.49% dividend while Plug Power Inc pays none. Which is the better fit depends on your goals.
| GSK | PLUG | |
|---|---|---|
Market Cap | $101.34B | $3.08B |
Sector | Health | Industrials |
52-Week High | $61.18 | $4.14 |
52-Week Low | $36.20 | $1.40 |
Enterprise Value | $121.95B | $3.87B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
Plug Power trades at $2.27, up 4.61% today but remains in a bearish technical trend with negative profitability metrics. The company reported a net loss of $1.63 billion on $710 million revenue in 2025, though recent quarterly earnings showed mixed results with a Q1 2026 miss. News highlights include a 50MW electrolyzer order in Australia and asset sales aimed at boosting liquidity, while analyst consensus is divided with a $2.92 price target.
The outlook hinges on Plug Power's path to projected 2028 profitability amid persistent cash burn and high short interest. Investment opportunity exists in hydrogen ecosystem growth, but risks include sustained losses, competitive pressure, and execution challenges in scaling operations globally.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →
